Insider Transactions in Q1 2025 at Arbutus Biopharma Corp (ABUS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2025
|
J. Christopher Naftzger General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
11,333
-11.61%
|
$33,999
$3.28 P/Share
|
|
Feb 04
2025
|
Michael J. Mc Elhaugh Interim President & CEO |
SELL
Open market or private sale
|
Direct |
23,790
-1.58%
|
$71,370
$3.28 P/Share
|
|
Feb 04
2025
|
Karen Sims Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,348
-15.41%
|
$58,044
$3.28 P/Share
|
|
Feb 04
2025
|
David C Hastings Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,183
-12.19%
|
$66,549
$3.28 P/Share
|